In this article

An employee works on the tail of a Boeing Co. Dreamliner 787 plane on the production line at the company’s final assembly facility in North Charleston, South Carolina.
Travis Dove | Bloomberg | Getty Images

Boeing on Tuesday warned about a new defect on its 787 Dreamliner planes and that it will delay deliveries of the wide-body aircraft, the manufacturer’s latest production issue.

“We are inspecting 787s in our inventory for a nonconforming condition related to a fitting on the horizontal stabilizer,” Boeing said in a statement. “Airplanes found to have a nonconforming condition will be reworked prior to ticket and delivery.”

Boeing said the issue isn’t related to flight safety and that planes in service can continue operating.

The problem is the latest in a spate of manufacturing issues on Boeing planes that have slowed if not paused deliveries of certain aircraft outright, just as airlines are clamoring for new planes to capitalize on the travel boom.

Boeing had paused deliveries of the planes for several weeks earlier this year because of a separate problem on a fuselage component on certain 787s. The latest issue currently doesn’t affect Boeing’s full-year outlook for Dreamliner deliveries, the company said. Boeing has estimated that it would deliver between 70 and 80 of the planes this year.

The company has also had to rework some of its bestselling 737 Max planes this year because of an issues with fittings in some planes’ aft fuselages, made by Spirit Aerosystems.

Boeing shares fell sharply on the news but largely recovered, and were recently down less than 1% in afternoon trading.

You May Also Like
Robinhood to launch in the UK in latest international expansion bid

Robinhood to launch in the UK in latest international expansion bid

A woman’s silhouette holds a smartphone with the Robinhood Markets logo in…
China central bank releases slate of support measures amid a deepening economic slump

China central bank releases slate of support measures amid a deepening economic slump

Pan Gongsheng, governor of the People’s Bank of China, delivers a speech…

For Warren Buffett and Berkshire Hathaway, the big issues haven’t changed

In this article BRK.A In early 2022, there have been some notable…
FDA approves Pfizer gene therapy Beqvez for treatment of hemophilia B

FDA approves Pfizer gene therapy Beqvez for treatment of hemophilia B

Pavlo Gonchar | Lightrocket | Getty Images The Food and Drug Administration…